In a challenging market environment, TNGX stock has reached a new 52-week low, with shares plummeting to $2.58. According to InvestingPro data, while the company maintains strong liquidity with a ...

Equities researchers at Leerink Partnrs issued their Q3 2025 earnings per share (EPS) estimates for Tango Therapeutics in a ...

In this article, we are going to take a look at where Tango Therapeutics Inc. (NASDAQ:TNGX) stands against the other promising cancer stocks. According to the World Health Organization (WHO ...

Detailed price information for Tango Therapeutics Inc (TNGX-Q) from The Globe and Mail including charting and trades.

Given the high short interest and the low number of shares outstanding, I expect a short squeeze to occur, which could lead to an increase in TNGX's share price thereafter. Despite the negative ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Research analysts at Leerink Partnrs issued their Q1 2025 EPS estimates for shares of Tango Therapeutics in a research report issued to clients and investors on Wednesday, February 5th. Leerink ...

Tango Therapeutics Shuts Early-Stage Cancer Study Due To Liver Toxicity Tango Therapeutics halts its TNG348 program due to liver toxicity issues found in dose escalation studies. The company will ...

Price (T.Rowe) U.S. Small-Cap Value Equity Trust 719.69k Sep 30, 2024 0.67% 2,180,648 Price (T.Rowe) Institutional Small-Cap Stock Fund 587.45k Sep 30, 2024 0.55% 1,779,985 Price (T.Rowe) U.S ...